Alexander Ngwube, MB,BS

Associate Professor

Default image

Contact

Alexander Ngwube, MB,BS

Associate Professor

Department

Pediatrics (Phoenix)

Position

Associate Professor

Books

  • Ngwube A., Unrelated donor hematopoietic stem cell transplantation for sickle cell disease 2017

Publications

  • Transplantation and cellular therapy
    Hans Rhea, Retrospective Analysis of Fresh Vs Cryopreserved Allogenic Bone Marrow Transplant within Pediatric Population: A Change in Practice Due to COVID-19 Pandemic
    30:2, p. S246 - S246 2024
  • Transplantation and cellular therapy
    Rahim Mahvish Qureshi, Impact of CMV Reactivation on Clinical Outcomes Post Allogeneic Stem Cell Transplant in Patients with Sickle Cell Disease
    30:2, p. S302 - S302 2024
  • Transplantation and cellular therapy
    Horan Fiona, Preservation of Pulmonary Function Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study
    30:2, p. S45 - S46 2024
  • Pediatrics (Evanston)
    Booth Natalie, Reversal of Cerebral Arteriopathy Post-Hematopoietic Stem Cell Transplant for Sickle Cell Disease 2024
  • Bone marrow transplantation (Basingstoke)
    Gabelli Maria, Abatacept treatment for autoimmune hemolytic anemia occurring post hematopoietic stem cell transplantation 2023
  • Blood
    Stenger Elizabeth, Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study
    142:Supplement 1, p. 4955 - 4955 2023
  • Blood
    Ngwube Alexander I., Abatacept-Prophylaxis Based Haploidentical Transplantation May Allow Sustained Engraftment and Offset Gvhd in Non-Malignant Disorders
    142:Supplement 1, p. 4901 - 4901 2023
  • Blood
    John Tami D., Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study
    142:Supplement 1, p. 4904 - 4904 2023
  • Blood
    Shah Niketa C., Outcomes after RIC and Abatacept-Based Acute and Chronic Gvhd Prophylaxis in Allogeneic Transplantation for Sickle Cell Disease - Can Calcineurin Inhibitor Use be Curtailed?
    142:Supplement 1, p. 2185 - 2185 2023
  • Current opinion in hematology
    Shah Niketa C., Mixed donor chimerism following stem cell transplantation for sickle cell disease 2023
  • Transplantation and cellular therapy
    Booth Natalie, Efficacy of Azacitidine and Prophylactic Donor Lymphocyte Infusion after HSCT in Pediatric Patients with Acute Myelogenous Leukemia: A Retrospective Pre-Post Study
    29:5, p. 330.e1 - 330.e7 2023
  • Transplantation and cellular therapy
    Guilcher Gregory MT, 391 - Clinical Outcomes and Long-Term Follow-up of Children with Mixed Myeloid Chimerism Following Hematopoietic Cell Transplantation (HCT) for Sickle Cell Disease (SCD)
    29:2, p. S296 - S297 2023
  • Transplantation and cellular therapy
    Kasow Kimberly A., 387 - Curing Children with Sickle Hemoglobinopathies of Varying Severity Early in Life with HLA-Matched Sibling Donor (MSD) Hematopoietic Cell Transplantation (HCT) Following a Reduced Intensity Conditioning (RIC) Regimen: A Sickle Transplant, Advocacy, a
    29:2, p. S293 - S294 2023
  • Pediatric Blood and Cancer
    Shah A., Investigating racial disparities in quality-of-life years after pediatric hematopoietic stem cell transplant
    70:9 2023
  • Therapeutic Advances in Hematology
    Ngwube A., Role of abatacept in the prevention of graft-versus-host disease: current perspectives
    14 2023
  • Pediatric Hematology and Oncology
    Ngwube A., Pre-hematopoietic stem cell transplantation lung computed tomography is not an alternative to PFT for pediatric patients with sickle cell disease 2023
  • JCO Precision Oncology
    Goode E., Diagnostic and Prognostic Implications of GNAS Inactivation in Sonic Hedgehog-Activated Medulloblastoma: Case Report with Comprehensive Molecular Profiling and Review of Literature
    6 2022
  • Pediatric Hematology and Oncology
    Goode E., Busulfan-based reduced toxicity conditioning regimen used in hematopoietic stem cell transplantation in HLH patients results in sustained donor chimerism
    38:4 2021
  • Transfusion
    Nizzi F., Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange
    60:12 2020
  • Journal of Pediatric Hematology/Oncology
    Hickman K., Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature
    42:7 2020
  • Pediatric Hematology and Oncology
    Huschart E., Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia
    38:2 2020
  • Transfusion
    Hess J., Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept
    58:9 2018
  • Biology of Blood and Marrow Transplantation
    Ngwube A., Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
    24:3 2018
  • Pediatric Blood and Cancer
    Beebe K., Vitamin D deficiency and outcomes in pediatric hematopoietic stem cell transplantation
    65:2 2018
  • Journal of Pediatric Hematology/Oncology
    Madden L.M., Late toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic malignancies in children
    37:2 2015
  • Pediatric Blood and Cancer
    Ngwube A., Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia
    62:7 2015
  • Journal of Clinical Rheumatology
    Kitcharoensakkul M., Scurvy revealed by difficulty walking: Three cases in young children
    20:4 2014
  • Clinical Pediatrics
    Ngwube A., Disseminated Salmonella osetomyelitis in a 2-year-old with sickle cell disease
    51:6 2012